These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9843160)

  • 1. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.
    Xu Y; Stokes AH; Roskoski R; Vrana KE
    J Neurosci Res; 1998 Dec; 54(5):691-7. PubMed ID: 9843160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.
    Asanuma M; Miyazaki I; Ogawa N
    Neurotox Res; 2003; 5(3):165-76. PubMed ID: 12835121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease.
    Kuhn DM; Arthur RE; Thomas DM; Elferink LA
    J Neurochem; 1999 Sep; 73(3):1309-17. PubMed ID: 10461926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosinase enhances the covalent modification of DNA by dopamine.
    Stokes AH; Brown BG; Lee CK; Doolittle DJ; Vrana KE
    Brain Res Mol Brain Res; 1996 Nov; 42(1):167-70. PubMed ID: 8915597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of catalase on the inactivation of tyrosinase by ascorbic acid and by cysteine or glutathione.
    Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):209-14. PubMed ID: 6192633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40.
    Andersson KK; Vassort C; Brennan BA; Que L; Haavik J; Flatmark T; Gros F; Thibault J
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):687-95. PubMed ID: 1352446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for alpha-synuclein in the regulation of dopamine biosynthesis.
    Perez RG; Waymire JC; Lin E; Liu JJ; Guo F; Zigmond MJ
    J Neurosci; 2002 Apr; 22(8):3090-9. PubMed ID: 11943812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of tyrosine hydroxylase activity by ascorbate in vitro and in rat PC12 cells.
    Wilgus H; Roskoski R
    J Neurochem; 1988 Oct; 51(4):1232-9. PubMed ID: 2901463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons.
    Kuhn DM; Arthur R
    J Neurosci; 1998 Sep; 18(18):7111-7. PubMed ID: 9736634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tyrosinase reduces cell viability in catecholaminergic neuronal cells.
    Higashi Y; Asanuma M; Miyazaki I; Ogawa N
    J Neurochem; 2000 Oct; 75(4):1771-4. PubMed ID: 10987861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O; Buu NT; Edwards DJ
    J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dopamine biosynthesis by tetrahydropapaveroline.
    Kim YM; Kim MN; Lee JJ; Lee MK
    Neurosci Lett; 2005 Sep; 386(1):1-4. PubMed ID: 16026929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-DOPA-quinone inactivates tryptophan hydroxylase and converts the enzyme to a redox-cycling quinoprotein.
    Kuhn DM; Arthur RE
    Brain Res Mol Brain Res; 1999 Nov; 73(1-2):78-84. PubMed ID: 10581400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of neurotropic drug actions on tyrosine hydroxylase activity and dopamine metabolism in clonal cell lines.
    Bräutigam M; Kittner B; Herken H
    Arzneimittelforschung; 1985; 35(1A):277-84. PubMed ID: 2859029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine hydroxylase activation and inactivation by protein phosphorylation conditions.
    Vrana KE; Allhiser CL; Roskoski R
    J Neurochem; 1981 Jan; 36(1):92-100. PubMed ID: 6109760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of tyrosine hydroxylase by pterin substrates following phosphorylation by cyclic AMP-dependent protein kinase.
    Roskoski R; Wilgus H; Vrana KE
    Mol Pharmacol; 1990 Oct; 38(4):541-6. PubMed ID: 1978241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage?
    Park S; Geddes TJ; Javitch JA; Kuhn DM
    J Biol Chem; 2003 Aug; 278(31):28736-42. PubMed ID: 12771134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maltol on the oxidation of DL-DOPA, dopamine, N-acetyldopamine (NADA), and norepinephrine by mushroom tyrosinase.
    Kahn V; Ben-Shalom N
    Pigment Cell Res; 1997 Jun; 10(3):139-49. PubMed ID: 9266600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-DOPA is a substrate for tyrosine hydroxylase.
    Haavik J
    J Neurochem; 1997 Oct; 69(4):1720-8. PubMed ID: 9326301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamine synthesis is mediated by tyrosinase in the absence of tyrosine hydroxylase.
    Rios M; Habecker B; Sasaoka T; Eisenhofer G; Tian H; Landis S; Chikaraishi D; Roffler-Tarlov S
    J Neurosci; 1999 May; 19(9):3519-26. PubMed ID: 10212311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.